COSCIENS Biopharma Inc T.AEZS

New Press Release - Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders

MILWAUKEE, June 7, 2024 /PRNewswire/ -- Ademi LLP is investigating Aeterna (Nasdaq: AEZS) for possible breaches of fiduciary duty and other violations of law in its transaction with Ceapro.Click here to learn how to join our investigation: https://www.ademilaw.com/case/aeterna-zentaris-inc or...read article.

[Schellaj]

Why does this article state the incorrect exchange rate for Ceapro to Aeterna shares?

[prophetoffactz]

It could have been written by an automated Ai program just fishing for business. The US has a lot of these investigation news releases flood a major even when the stock drops. AEZS has fallen from ~C$14 to ~C$10 as the warrants are converted. Now how many of the people who pushed the stock up to get the warrants may sell the warrants or maybe all of it. CZO's last financials were also

[Ciao]

There's a strong case here that CEAPRO's management did not act in shareholder's best interest in this merger. A class action lawsuit would be needed before the directors resign (usually when the company is close to bankruptcy). There was a call to have the CEO removed, but rather management decided to entrench themselves with job security in a merger that put themselves first. We